Dynamic Multidrug Therapies for HIV: A Control Theoretic Approach (Classic Reprint) - Softcover

Lawrence M. Wein

 
9781332258758: Dynamic Multidrug Therapies for HIV: A Control Theoretic Approach (Classic Reprint)

Synopsis

Excerpt from Dynamic Multidrug Therapies for Hiv: A Control Theoretic Approach

Uninfected cd4jr cells increase because of (exponential) proliferation in peripheral tissue compartments secondary lymphoid organs) and/or (linear) production from a pool of precursors the thymus). For simplicity, we assume a constant production rate A. In addition, we let u, a, and k, denote the respective natural death rates of uninfected CD4+ cells, cells infected by strain i and free virus of strain z.

About the Publisher

Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com

This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.

"synopsis" may belong to another edition of this title.

Product Description

Excerpt from Dynamic Multidrug Therapies for Hiv: A Control Theoretic Approach

Uninfected cd4jr cells increase because of (exponential) proliferation in peripheral tissue compartments secondary lymphoid organs) and/or (linear) production from a pool of precursors the thymus). For simplicity, we assume a constant production rate A. In addition, we let u, a, and k, denote the respective natural death rates of uninfected CD4+ cells, cells infected by strain i and free virus of strain z.

About the Publisher

Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com

This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.

About the Author

Stefanos Zenios is the Charles A. Holloway Professor at the Graduate School of Business, Stanford University. His pioneering work on maximizing the benefits of medical technology to patients when resources are limited has influenced policies in the US and Europe. He has quantified the ethical implications of technology allocation choices on patients and society as featured in the Financial Times and Times.com. At Stanford University, he was the first to introduce courses on the interface between medicine, engineering, and management in the MBA curriculum. Dr Zenios advises medical device and biopharmaceutical companies on health economics and outcomes studies for marketing and reimbursement strategies. He is also a co-founder of Culmini Inc., a company funded by the National Institutes of Health to develop web-tools that help patients and families with difficult choices.

"About this title" may belong to another edition of this title.

Other Popular Editions of the Same Title